Recent News +++

Phase I DSTP3086S Trial Results Published

Media Relations by PCCTC November 11, 2019

PCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...

Learn More

Advocacy Symposium Led by PCCTC Investigator

Media Relations by PCCTC August 10, 2018

Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...

Learn More

Blood Test Predicts Treatment Response, Survival in Metastatic Disease

Media Relations by PCCTC June 29, 2018

PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....

Learn More

The PCCTC Is Expanding Its Trial Management Capabilities

Media Relations by PCCTC June 12, 2018

To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...

Learn More

Early Development Led by the PCCTC, FDA Approval Now Sought for Apalutamide

Media Relations by Jason Harris - OncLive October 12, 2017

A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...

Learn More

Team PCCTC Joins Movember Effort

Media Relations by PCCTC November 1, 2016

Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...

Learn More
View More News +

Follow Us

RT @DoraTrial: @DoraTrial, an open-labeled, randomized, phase III study of docetaxel versus docetaxel in combination with radium-223 in sub…
RT @IRONMANregistry: 🇪🇸 ¡Bienvenido @chpcastellon (PI: @Dav_Lorente), the latest site to open our International Registry to Improve Outcome…
Olaparib (Lynparza), a drug developed in early phase @ThePCCTC trials, granted priority FDA review for certain type…

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.